Skip to Content

Join the 'Deep Vein Thrombosis Prophylaxis after Knee Replacement Surgery' group to help and get support from people like you.

Deep Vein Thrombosis Prophylaxis after Knee Replacement Surgery News

There May Be a Big Medical Upside to Being Short

Posted 6 Sep 2017 by Drugs.com

TUESDAY, Sept. 5, 2017 – There may be at least one advantage to being short: a lower risk for dangerous blood clots in the veins, a new study shows. These clots, called venous thromboembolisms, include blockages known as DVTs (deep vein thrombosis), which typically start in the legs and can travel to the lungs, raising a person's odds for stroke. Sometimes DVTs occur after long-haul flights, so ...

FDA Medwatch Alert: Eliquis (apixaban) 5 mg tablets: Recall One Lot- Bottle labeled as Eliquis 5 mg was found to contain Eliquis 2.5 mg tablets

Posted 13 Jun 2017 by Drugs.com

ISSUE: Bristol-Myers Squibb Company is voluntarily recalling one lot (#HN0063) of Eliquis 5 mg tablets to the consumer level. This lot was distributed nationwide in the U.S. to wholesalers and retail pharmacies in February 2017. Bristol-Myers Squibb is taking this precautionary measure based on a customer complaint that a bottle labeled as Eliquis 5 mg was found to contain Eliquis 2.5 mg tablets. ...

Knee Replacement Patients May Be Able to Hit the Shower Sooner

Posted 27 May 2016 by Drugs.com

THURSDAY, May 26, 2016 – Knee surgery patients are usually instructed to wait two weeks after surgery to take a shower to reduce the risk of infection. But a small new study suggests this may not be necessary. Researchers found no differences in bacterial swabs from those who waited two weeks to shower compared with those allowed to shower after about two days. That's no doubt welcome news to ...

Health Tip: Know Your Risk for Deep Vein Thrombosis

Posted 4 Aug 2015 by Drugs.com

-- A dangerous condition called deep vein thrombosis (DVT) occurs when a blood clot develops in a vein deep inside the body. The U.S. National Heart Lung and Blood Institute mentions these potential risk factors: Having had a previous DVT, or taking medication that thickens the blood or promotes clotting. Having had surgery, a broken bone or other injury that affects a deep vein. Having reduced ...

FDA Approves Eliquis to Reduce Risk of Blood Clots Following Hip Or Knee Replacement Surgery

Posted 18 Mar 2014 by Drugs.com

PRINCETON, N.J. & NEW YORK-- Friday, March 14, 2014 (BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) approved a Supplemental New Drug Application (sNDA) for Eliquis (apixaban) for the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE), in patients who have ...

Diabetes Doesn't Seem to Raise Risks After Knee Replacement

Posted 27 Feb 2013 by Drugs.com

WEDNESDAY, Feb. 27 – People with diabetes who undergo knee replacement surgery are not at greater risk for infection, deep vein thrombosis (a type of blood clot), or other complications following the procedure than people without diabetes, new study findings indicate. "This current study suggests that patients with diabetes who have higher glucose [blood sugar] levels may not be at greater risk ...

FDA Expands Use of Xarelto to Treat, Reduce Recurrence of Blood Clots

Posted 2 Nov 2012 by Drugs.com

November 2, 2012 – The U.S. Food and Drug Administration today expanded the approved use of Xarelto (rivaroxaban) to include treating deep vein thrombosis (DVT) or pulmonary embolism (PE), and to reduce the risk of recurrent DVT and PE following initial treatment. Blood clots occur when blood thickens and clumps together. DVT is a blood clot that forms in a vein deep in the body. Most deep vein ...

Joint Replacement Patients Face Blood Clot Risk in Hospital

Posted 17 Jan 2012 by Drugs.com

TUESDAY, Jan. 17 – One of every 100 people undergoing knee replacement surgery and 1 of 200 people having hip replacement surgery will develop a blood clot before they leave the hospital, even if they take steps to prevent the development of these blood clots, a new evidence review suggests. A deep venous thrombosis (DVT) or blood clot can form deep within the veins, usually in the leg. The real ...

FDA Approves Xarelto (rivaroxaban) to Prevent Deep Vein Thrombosis in Patients Undergoing Knee or Hip Replacement Surgery

Posted 1 Jul 2011 by Drugs.com

Raritan, NJ (July 1, 2011) — Janssen Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Xarelto (rivaroxaban tablets), a novel, once-daily, oral anticoagulant for the prevention (prophylaxis) of deep vein thrombosis (DVT) which may lead to a pulmonary embolism (PE) in people undergoing knee or hip replacement surgery. "The approval of once-daily X ...

Ask a Question

Further Information

Related Condition Support Groups

Deep Vein Thrombosis - Prophylaxis

Related Drug Support Groups

warfarin, Coumadin, Xarelto, Eliquis, Lovenox, rivaroxaban, apixaban, Clexane, enoxaparin, view more... Arixtra, Jantoven, fondaparinux, Clexane Forte, Lovenox HP, Arixtra 5 mg / dose, Arixtra 7.5 mg / dose, Arixtra 10 mg / dose